➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Moodys
AstraZeneca
McKinsey
Johnson and Johnson

Last Updated: June 15, 2021

DrugPatentWatch Database Preview

Tetrabenazine - Generic Drug Details

« Back to Dashboard

What are the generic sources for tetrabenazine and what is the scope of patent protection?

Tetrabenazine is the generic ingredient in two branded drugs marketed by Actavis Labs Fl Inc, Ajanta Pharma Ltd, Apotex, Bionpharma Inc, Dr Reddys, Hetero Labs Ltd V, Hikma, Lupin Ltd, Mylan, Piramal Hlthcare Uk, Sun Pharm, and Bausch, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for tetrabenazine. Thirteen suppliers are listed for this compound.

Drug Prices for tetrabenazine

See drug prices for tetrabenazine

Recent Clinical Trials for tetrabenazine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kirk A. FreyPhase 1
Adeptio PharmaceuticalsPhase 1
Dr. Reddy's Laboratories LimitedPhase 1

See all tetrabenazine clinical trials

Pharmacology for tetrabenazine
Medical Subject Heading (MeSH) Categories for tetrabenazine

US Patents and Regulatory Information for tetrabenazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys TETRABENAZINE tetrabenazine TABLET;ORAL 209284-002 Jan 8, 2018 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Hikma TETRABENAZINE tetrabenazine TABLET;ORAL 209739-001 Apr 8, 2019 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Hetero Labs Ltd V TETRABENAZINE tetrabenazine TABLET;ORAL 204574-002 Feb 3, 2016 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
AstraZeneca
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.